Reproductive · Breast Pathology
The facts most likely to be tested
Fibroadenoma is the most common benign breast tumor in women of reproductive age.
Physical examination reveals a firm, painless, well-circumscribed, and highly mobile breast mass often described as a breast mouse.
The mass is estrogen-sensitive, typically increasing in size during the luteal phase of the menstrual cycle or during pregnancy.
Initial diagnostic evaluation for a palpable breast mass in a patient under 30 years old is a breast ultrasound.
Ultrasound findings typically demonstrate a hypoechoic, well-defined solid mass with smooth borders.
Definitive diagnosis is confirmed via core needle biopsy if the mass is indeterminate, rapidly growing, or in patients over 30.
Management for a confirmed, asymptomatic fibroadenoma is clinical observation and reassurance.
Vignette unlocked
A 22-year-old female presents to the clinic for a self-detected breast lump. She reports no nipple discharge, skin changes, or family history of breast cancer. On physical exam, there is a 2 cm firm, nontender, highly mobile mass in the upper outer quadrant of the right breast. The mass has well-defined borders and does not feel fixed to the underlying tissue. A breast ultrasound is performed, revealing a hypoechoic solid mass with circumscribed margins.
What is the most appropriate next step in management?
Clinical observation and reassurance
The clinical presentation and ultrasound findings are classic for a fibroadenoma, which is a benign condition that can be managed with observation in young, asymptomatic patients.
Full handout
High yield triage
Etiology / Epidemiology
Most common benign breast tumor in adolescents and women <30. Driven by estrogen sensitivity.
Clinical Manifestations
Painless, breast mouse, firm, mobile, rubbery mass. Does not change with menstrual cycle.
Diagnosis
Initial imaging is ultrasound. Definitive diagnosis via core needle biopsy if indeterminate.
Treatment
Observation with serial ultrasound is standard. Surgical excision only for rapid growth or patient preference.
Prognosis
Excellent prognosis. No increased risk of breast cancer development.
Full handout
Epidemiology & Etiology
Commonly presents in the second and third decades of life. It is a hormone-dependent lesion that often regresses after menopause. Prevalence is higher in African American women.
Pertinent Anatomy
Arises from the terminal duct lobular unit of the breast. The mass is encapsulated and distinct from surrounding breast parenchyma.
Pathophysiology
Represents a hyperplastic process of both stromal and epithelial components. Growth is stimulated by estrogen and progesterone, explaining why they may enlarge during pregnancy or lactation.
Clinical Manifestations
Presents as a solitary, painless, well-circumscribed mass. It is classically described as a breast mouse due to its high mobility on palpation. Red flags include skin dimpling, nipple retraction, or fixed masses, which mandate investigation for malignancy.
Diagnosis
First-line imaging is ultrasound, which typically shows a well-defined, hypoechoic mass. Core needle biopsy is the gold standard for definitive diagnosis if imaging is suspicious or the patient is >35 years old.
Treatment
Conservative management with clinical breast exam and serial ultrasound is appropriate for most patients. Surgical excision is reserved for rapidly enlarging masses or patient anxiety. Avoid unnecessary surgery as it may cause breast deformity.
Prognosis
The condition is benign with zero malignant potential. Most lesions remain stable or regress over time, requiring only routine monitoring.
Differential Diagnosis
Breast Cyst: fluid-filled, often tender, changes with cycle
Phyllodes Tumor: rapid growth, large size, leaf-like architecture
Breast Carcinoma: hard, fixed, irregular borders, skin changes
Fat Necrosis: history of trauma, ecchymosis, firm irregular mass
Intraductal Papilloma: associated with unilateral nipple discharge